• 1. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474
• 2. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
• 3. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 4. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 5. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Sulfanilides

Introduction to 4-Ethyl-N-(4-hydroxyphenyl)benzenesulfonamide (CAS No. 92248-71-0)

4-Ethyl-N-(4-hydroxyphenyl)benzenesulfonamide, identified by its Chemical Abstracts Service (CAS) number 92248-71-0, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical and medicinal chemistry. This compound belongs to the class of sulfonamides, which are well-documented for their broad spectrum of biological activities. The structural features of 4-Ethyl-N-(4-hydroxyphenyl)benzenesulfonamide, particularly the presence of an ethyl group and a hydroxyl-substituted phenyl ring, contribute to its unique chemical properties and potential therapeutic applications.

The sulfonamide moiety in 4-Ethyl-N-(4-hydroxyphenyl)benzenesulfonamide is a key pharmacophore that interacts with various biological targets, including enzymes and receptors. This interaction is often modulated by the substituents attached to the sulfonamide core, such as the ethyl group and the hydroxyl group on the phenyl ring. The hydroxyl group, in particular, can participate in hydrogen bonding interactions, enhancing the compound's binding affinity and selectivity.

Recent advancements in computational chemistry and molecular modeling have facilitated a deeper understanding of the structural-activity relationships (SAR) associated with 4-Ethyl-N-(4-hydroxyphenyl)benzenesulfonamide. These studies have revealed that subtle modifications in the substituent patterns can significantly alter the biological activity of sulfonamides. For instance, the ethyl group at the N-position can influence the compound's solubility and metabolic stability, while the hydroxyl group on the phenyl ring can enhance its interaction with specific biological targets.

In terms of pharmacological activity, 4-Ethyl-N-(4-hydroxyphenyl)benzenesulfonamide has been investigated for its potential role in various therapeutic areas. One of the most promising applications is in anti-inflammatory and anti-microbial research. The sulfonamide scaffold is known to exhibit inhibitory effects on enzymes such as dihydropteroate synthase (DHPS), which is crucial for bacterial folate metabolism. This mechanism makes 4-Ethyl-N-(4-hydroxyphenyl)benzenesulfonamide a candidate for developing novel antibiotics targeting resistant strains.

Furthermore, studies have suggested that 4-Ethyl-N-(4-hydroxyphenyl)benzenesulfonamide may possess anti-cancer properties. The ability of sulfonamides to inhibit key enzymes involved in tumor metabolism and proliferation has been well-documented. The unique structural features of this compound could potentially lead to the development of targeted therapies that selectively inhibit cancer cell growth while minimizing side effects on healthy cells.

The synthesis of 4-Ethyl-N-(4-hydroxyphenyl)benzenesulfonamide involves multi-step organic reactions, typically starting from readily available aromatic precursors. The process often includes sulfonylation, nucleophilic substitution, and functional group transformations to achieve the desired structure. Advances in synthetic methodologies have enabled more efficient and scalable production of this compound, making it more accessible for further research and development.

One of the challenges in working with 4-Ethyl-N-(4-hydroxyphenyl)benzenesulfonamide is its solubility profile. Sulfonamides generally have moderate solubility in water due to their polar nature, which can be advantageous for certain applications but may limit others. Researchers have explored various strategies to improve solubility, such as derivatization or using co-solvents, which could enhance its bioavailability and therapeutic efficacy.

Recent clinical trials have begun to explore the potential of sulfonamides like 4-Ethyl-N-(4-hydroxyphenyl)benzenesulfonamide in treating inflammatory diseases. The anti-inflammatory properties attributed to sulfonamides are primarily due to their ability to modulate cytokine production and inhibit inflammatory pathways. Preliminary results from these trials are promising, indicating that this class of compounds could offer new treatment options for conditions such as rheumatoid arthritis and inflammatory bowel disease.

The future direction of research on 4-Ethyl-N-(4-hydroxyphenyl)benzenesulfonamide lies in expanding its therapeutic applications through structure-activity relationship studies and drug design innovations. By leveraging computational tools and high-throughput screening techniques, scientists aim to identify new derivatives with enhanced potency and reduced toxicity. Additionally, exploring combination therapies involving 4-Ethyl-N-(4-hydroxyphenyl)benzenesulfonamide with other drugs could provide synergistic effects that improve patient outcomes.

In conclusion, 4-Ethyl-N-(4-hydroxyphenyl)benzenesulfonamide (CAS No. 92248-71-0) represents a promising compound with diverse biological activities and therapeutic potential. Its unique structural features make it a valuable scaffold for developing novel pharmaceuticals targeting various diseases. As research continues to uncover new applications and optimize synthetic pathways, this compound is poised to play a significant role in future medical advancements.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)